Court Square acquisition of The Harvard Drug Group from H.I.G. Capital
Acquisition08/04/2010
H.I.G. Capital announced the completed sale of The Harvard Drug Group to Court Square Capital Partners on April 8, 2010. The transaction transferred a generics-focused pharmaceutical distributor from one private equity sponsor to another. H.I.G. had partnered with management in December 2006, and its exit announcement described complementary acquisitions and earnings growth during the holding period. Harvard Drug served independent, regional and national pharmacies as well as hospitals, long-term-care facilities and government customers. Wells Fargo Securities advised Court Square on the transaction. The parties did not disclose transaction consideration or an ownership percentage in the announcement; those fields remain unspecified.
Type
Acquisition
Announced
08/04/2010
Amount
Financial data requires access
Asset class
Private Equity
Reported parties
H.I.G. Capital; Court Square Capital Partners; The Harvard Drug Group